For 18 years, this global initiative has facilitated networking and dialogue amongst individuals working in and around the pharmaceutical industry and MedComms, focusing on specialist medical education, medical communications and medical publishing activities. Please join the conversation on LinkedIn, using hashtag #MedComms.
The aim is to host a regular small meeting with 2-4 speakers presenting on various topics of direct relevance to MedComms. Importantly the presentations will be filmed for webcasting for free access by the global community afterwards. Topics will be announced in advance but we believe we can guarantee a useful educational and networking session every time. So make a note of the dates now. It's the first Wednesday of every month (except when it isn't!).
Scroll down for copies of the presentation slides and the full webcasts, which are freely available.
Date: 1 June 2016
Venue: Magdalen Centre, The Oxford Science Park, Robert Robinson Avenue, Oxford OX4 4GE [DIRECTIONS]
Timing:
10.00 Registration and coffee
10.30 Formal session
EMWA - what does it offer medical writers? Jo Whelan, Freelance medical writer, Textpharm Ltd talks about EMWA, the European Medical Writers Association, a network of professionals that represents, supports and trains medical communicators. Learn about what EMWA does, its relevance to writers in the medical communications sector, and the benefits of being a member.
The EMWA guidelines and position statement on the role of medical writers in peer-reviewed publications Jo Whelan, Freelance medical writer, Textpharm Ltd explains how the EMWA guidelines have been widely cited and provides practical guidance on ethical working for professional medical writers who help develop peer-reviewed publications. Get familiar with the guidelines and learn about how they sit alongside other guidance on good publication practice.
Know Your Audience: Informed Decision-Making in Congress Submissions Helen Chambers, Publication Manager at Costello Medical Consulting discusses the Good Publication Practice guidelines (GPP3) regarding redundant publications, and whether sufficient information is available regarding congress attendees to ensure that resubmitted abstracts reach new and varied audiences.
To make sure you're included in announcements about future events just email Peter Llewellyn, if you haven't already done so, to register your interest.
WHAT ELSE?
This meeting was free to attend thanks to the generosity of the corporate sponsors
This web site and associated activities are being managed by NetworkPharma Ltd, company registration 4392836
Registered office: 6-7 Citibase, New Barclay House, 234 Botley Road, Oxford, OX2 0HP, UK Email: support@networkpharma.com
